Swiss Medica Exhibits at Shoppers Drug Mart Pharmacy Conference; Meets With Over 1000 Pharmacists.TORONTO -- Swiss Medica medica (māˑ·dē·k (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :SWME) exhibited at the Shoppers Pharmacy Conference on October 16th at the Toronto Congress Centre The Toronto Congress Centre (TCC) is currently the third largest convention centre in Canada. It is located in Etobicoke, Ontario at 650 Dixon Road, near the Toronto Pearson International Airport and International Centre. , which was attended by approximately 1,200 pharmacists. The purpose of the conference was to educate and inform the Shoppers Drug Mart For the Washington, DC area grocery chain, see . Shoppers Drug Mart Corporation TSX: SC is Canada's largest pharmacy chain with more than 1000 stores operating under the names Shoppers Drug Mart across 9 provinces and 2 territories and Pharmaprix in Quebec. pharmacists about the products they carry in their stores. Swiss Medica's Vice President of Sales and Marketing, Michael Bain, and staff met with 90% of the pharmacists attending the show, providing marketing information and samples of the O24(TM) Essential Oil Pain Neutralizer. Mr. Bain held eight informational sessions with larger groups of pharmacists to help explain the O24(TM) pain relief product and to respond to the overwhelming consumer response the pharmacists recently received during the latest media coverage of the product. Mr. Bain said, "It was exciting to engage such a large number of highly respected pharmacists and to hear them praise the O24(TM) Essential Oil Pain Neutralizer. They were eager to learn more about the product that has been driving a large number of consumers into their stores after our recent media appearances. Many pharmacists had announced they had resold O24(TM) multiple times during the past six weeks." Other Shoppers Drug Mart Pharmacy Conferences are scheduled later this year in Montreal and Calgary. About Swiss Medica Inc. Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our market share through focused distribution strategies in multiple sales channels. Swiss Medica's mission is to be a world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please visit our websites at www.swissmedica.com and www.024zone.com Swiss Medica's flagship product A primary product of a company, which is typically why the company was founded and/or what made it well known. For example, MS-DOS, Windows and the Microsoft Office suite have been flagship products of Microsoft. CorelDRAW is a flagship product of Corel Corporation. , the 024(TM) Essential Oil Pain Neutralizer, holds US Patent #6,444,238B1. The 024(TM) pain relief solution has been used, recommended and praised for its fast-acting and long-lasting benefits by healthcare professionals in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. , Canada and in Europe. O24 is widely available throughout Canada in leading pharmacies and natural food stores. It is available in the United States and elsewhere by visiting www.024zone.com, for ordering details and store locators. Forward-looking statements in this news release are made pursuant to the "Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. " provisions of the United States Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, risks relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc the ability to close transactions being contemplated, risks related to international sales and potential foreign currency exchange fluctuations, continued acceptance of Swiss Medica's products, increased levels of competition, technological changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica's periodic reports filed with the United States Securities and Exchange Commission and other regulatory authorities. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion